Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Salestools Logo

Salestools

#1 AI-agent för säljteam och Go-to-Market-team. Sälj mer, snabbare, med mindre ansträngning.

Produkt

  • AI-säljagenter
  • Intentionsdata
  • Teknologidata
  • Besöksspårning
  • Medpilot
  • Social Försäljning

Lösningar

  • Kundservice
  • E-handel
  • SaaS
  • Företag
  • Småföretag

Resurser

  • Rapporten
  • Dokumentation
  • API-referens
  • Hjälpcenter
  • Blogg
  • Fallstudier
  • Webbinarier

Företag

  • Om oss
  • Karriärer
  • Press
  • Kontakt
  • Partners

Våra kontor

  • New York, HQ
  • Bukarest, AI-forskningslabb
  • Zug, Schweiz

© 2026 Salestools. Alla rättigheter förbehållna.

Datavillkor och SäkerhetSekretesspolicyAnvändarvillkorAcceptable Use
Alla system fungerar
Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Back to Reports
Fundraising

Church & Dwight

Church & Dwight Raises $30B in Public

500 Charles Ewing Boulevard, Ewing, NJ 08628January 1, 20242 min read
Employees
5500+

Church & Dwight Raises $30B in Public


Church & Dwight has successfully raised $30B in a Public at a $32B valuation led by Public.


Company Overview


Church & Dwight is a Consumer Goods company headquartered in 500 Charles Ewing Boulevard, Ewing, NJ 08628, founded in 1846 with 5500+ employees.


Consumer packaged goods company


Fundraising Details


  • Amount Raised: $30B
  • Round Type: Public
  • Valuation: $32B
  • Date: 2024-01-01
  • Investors: Public

About Church & Dwight


Consumer packaged goods company The company is positioned in the Consumer Goods sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 500 Charles Ewing Boulevard, Ewing, NJ 08628
  • Founded: 1846
  • Team Size: 5500+
  • Industry: Consumer Goods

What This Means


This funding round demonstrates strong investor confidence in Church & Dwight's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Consumer Goods sector continues to attract significant investment as companies innovate to meet evolving market demands. Church & Dwight's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $32B valuation marks an important milestone for Church & Dwight, positioning the company among notable players in the Consumer Goods industry.


Looking Ahead


With this new capital, Church & Dwight is well-positioned to execute on its growth strategy and continue building innovative solutions in the Consumer Goods space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about Church & Dwight, visit their headquarters at 500 Charles Ewing Boulevard, Ewing, NJ 08628.

Company Info

Headquarters
500 Charles Ewing Boulevard, Ewing, NJ 08628
Founded
1846
Team Size
5500+

Topics

Fundraising(2912)Public(771)Consumer GoodsChurch & Dwight

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free